Magnetically guided catheterisation
Niobe®
MHL currently features the following centre for Niobe® heart catheterisation
Klinik Hirslanden, Zurich, Switzerland
Klinik Hirslanden is the flagship hospital of the Hirslanden Group, Switzerland's largest private healthcare provider. The Klinik invests heavily in the latest medical technologies, including Trilogy® stereotactic radiotherapy, Intrabeam® single-treatment radiotherapy for certain breast cancer tumours, CyberKnife® radiosurgery, da Vinci® minimally invasive robotic surgery and much more
World-leading treatment centres
Non-invasive medical technologies
Information for doctors and patients
Niobe® is used to treat atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome and AV nodal reentry tachycardia.
Whilst catheterisation is an inavasive procedure, the use of magnetic guidance from outside the body rather than mechanical means within makes this a welcome advance. One or more treatment centres promoted by MHL offers the Niobe® system and as this may not already be well known in some countries we are püleased to provide some details here.
Whilst catheterisation is an inavasive procedure, the use of magnetic guidance from outside the body rather than mechanical means within makes this a welcome advance. One or more treatment centres promoted by MHL offers the Niobe® system and as this may not already be well known in some countries we are püleased to provide some details here.
Note: MHL has no contractual or financial relationship with Strereotaxis, the manufacturers of the Niobe® system. For full details visit the Stereotaxis web site.
Magnetic guidance replaces wires
Catheters are inserted through veins in the groin and then guided to the heart. Until recently they were positioned using guidewires but the Niobe® system enables the surgeon to navigate the catheter remotely. The patient lies between two large magnetic coils, which are used to manipulate small magnets integrated into the tip of the soft and flexible catheter.
The surgeon views the catheter on his monitor and re-aligns the magnetic field, to guide the catheter very accurately, to the millimetre, into the heart chamber. The electrophysiologist can advance and retract the catheter in the heart with a separate control module.
The surgeon views the catheter on his monitor and re-aligns the magnetic field, to guide the catheter very accurately, to the millimetre, into the heart chamber. The electrophysiologist can advance and retract the catheter in the heart with a separate control module.
The strong magnetic field and special flexible catheter ensure particularly stable contact with the heart muscle. In addition, the catheters used are extremely soft and flexible to minimise trauma to the heart and blood vessel walls.
External magnetic guidance replaces internal guide wires
X-ray exposure is considerably reduced for doctor and patient alike.
The clinician decides which patients are to be treated with the Niobe® system and which are to be treated manually. The decisive criteria imclude the size of the atrium, secondary disorders, the patient’s condition and the course of the irregular heart rhythm. Where Niobe® is used, the specialist’s experience plays a vital role in analysing and co-ordinating the information provided by the various systems: X-rays, stereotaxis, the mapping system (Carto, NavX) and the electrical signals.
MHL
Healthcare for the
Internet Age
Internet Age
from Medilux Healthcare Ltd
www.mediluxretail.co.uk
© 2006-2009 Medilux Healthcare Ltd
MHL main international web sites
For further information visit the Klinik Hirslanden Cardiology page on our web site www.mhlclinics.com